Cargando…
老年肺癌患者的免疫治疗疗效分析
BACKGROUND AND OBJECTIVE: Immunotherapy represented by immune checkpoint inhibitors (ICIs) has become the standard treatment for patients with non-oncogenic advanced non-small cell lung cancer (NSCLC). While lung cancer is most prevalent in elderly patients, these patients are rarely included in piv...
| Formato: | Online Artículo Texto |
|---|---|
| Lenguaje: | English |
| Publicado: |
中国肺癌杂志编辑部
2022
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9244504/ https://www.ncbi.nlm.nih.gov/pubmed/35747919 http://dx.doi.org/10.3779/j.issn.1009-3419.2022.102.16 |